LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Wall, E. C.; Gritzfeld, J. F.; Scarborough, M.; Ajdukiewicz, K. M. B.; Mukaka, M.; Corless, C.; Lalloo, D. G.; Gordon, S. B. (2014)
Publisher: W.B. Saunders
Journal: The Journal of Infection
Languages: English
Types: Article
Subjects: Africa, qu_460, Bacterial load, Cytokine response, Infectious Diseases, wa_395, wc_217, Bacterial meningitis; Streptococcus pneumoniae; Bacterial load; Cerebrospinal fluid; Cytokine response; Mortality; Africa, Article, wc_245, qw_568, Cerebrospinal fluid, Mortality, Bacterial meningitis, Microbiology (medical), Streptococcus pneumoniae
Objective\ud \ud Bacterial meningitis in sub-Saharan Africa is predominantly caused by Streptococcus pneumoniae, is often associated with HIV co-infection and mortality rates are double those seen in better resourced settings.\ud \ud Methods\ud \ud To investigate the cause of this excessive mortality we quantified the pneumococcal DNA load and six common pro-inflammatory cytokines in the cerebrospinal fluid (CSF) of Malawian adults with culture proven pneumococcal meningitis and correlated the results to clinical parameters and outcome. There are currently no published data relating bacterial load to outcome in adults with pneumococcal meningitis.\ud \ud Results\ud \ud The mean age of patients was 32 years, 82% were HIV infected and 49% had died by day 40. CSF bacterial loads were high (median 6.5 × 105 copies/ml CSF) and there was no significant variation in bacterial load between survivors and non-survivors. All pro-inflammatory CSF cytokines were elevated in the CSF, with no clinically important differences between survivors and non-survivors. HIV status did not affect the CSF bacterial load or cytokine response.\ud \ud Conclusion\ud \ud Mortality from pneumococcal meningitis in adults in sub-Saharan Africa is not related to pneumococcal bacterial load. More research is needed to understand the very high mortality from meningitis in this region.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Tsai CJ, Griffin MR, Nuorti JP, Grijalva CG. Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States. Clin Infect Dis Official Publ Infect Dis Soc Am 2008;46(11): 1664e72 [Epub 2008/04/25].
    • 2. Brouwer MC, Tunkel AR, van de Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev 2010;23(3):467e92 [Epub 2010/07/09].
    • 3. Wall EC, Everett DB, Mukaka M, Bar-Zeev N, Feasey N, Jahn A, et al. Bacterial meningitis in Malawian adults, adolescents, and children during the era of antiretroviral scale-up and haemophilus influenzae type b vaccination, 2000e2012. Clin Infect Dis Official Publ Infect Dis Soc Am 2014 May;58(10): e137e145. http://dx.doi.org/10.1093/cid/ciu057.
    • 4. van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004;351(18):1849e59 [Epub 2004/10/29].
    • 5. Wall E, Carwright K, Scarborough M, Ajdukiewicz K, Goodson P, Mwambene J, et al. High mortality amongst adolescents and adults with bacterial meningitis in sub-Saharan Africa: an analysis of 715 cases from Malawi. PLoS One 2013 Jul 19;8(7): e69783. http://dx.doi.org/10.1371/journal.pone.0069783.
    • 6. Carrol ED, Guiver M, Nkhoma S, Mankhambo LA, Marsh J, Balmer P, et al. High pneumococcal DNA loads are associated with mortality in Malawian children with invasive pneumococcal disease. Pediatr Infect Dis J 2007;26(5):416e22 [Epub 2007/05/01].
    • 7. Roine I, Saukkoriipi A, Leinonen M, Peltola H. Microbial genome count in cerebrospinal fluid compared with clinical characteristics in pneumococcal and haemophilus influenzae type b meningitis in children. Diagn Microbiol Infect Dis 2009;63(1): 16e23 [Epub 2008/11/08].
    • 8. Rello J, Lisboa T, Lujan M, Gallego M, Kee C, Kay I, et al. Severity of pneumococcal pneumonia associated with genomic bacterial load. Chest 2009;136(3):832e40 [Epub 2009/05/13].
    • 9. Vazquez JA, Adducci Mdel C, Coll C, Godoy Monzon D, Iserson KV. Acute meningitis prognosis using cerebrospinal fluid interleukin6 levels. J Emerg Med 2012;43(2):322e7 [Epub 2011/12/07].
    • 10. Bociaga-Jasik M, Garlicki A, Ciesla A, Kalinowska-Nowak A, Sobczyk-Krupiarz I, Mach T. The diagnostic value of cytokine and nitric oxide concentrations in cerebrospinal fluid for the differential diagnosis of meningitis. Adv Med Sci 2012;57(1): 142e7 [Epub 2012/04/05].
    • 11. Scarborough M, Gordon SB, Whitty CJ, French N, Njalale Y, Chitani A, et al. Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. N Engl J Med 2007;357(24): 2441e50 [Epub 2007/12/14].
    • 12. Ajdukiewicz KM, Cartwright KE, Scarborough M, Mwambene JB, Goodson P, Molyneux ME, et al. Glycerol adjuvant therapy in adults with bacterial meningitis in a high HIV seroprevalence setting in Malawi: a double-blind, randomised controlled trial. Lancet Infect Dis 2011;11(4):293e300 [Epub 2011/02/22].
    • 13. Wall EC, Gordon SB, Hussain S, Goonetilleke UR, Gritzfeld J, Scarborough M, et al. Persistence of pneumolysin in the cerebrospinal fluid of patients with pneumococcal meningitis is associated with mortality. Clin Infect Dis Official Publ Infect Dis Soc Am 2012;54(5):701e5 [Epub 2012/01/13].
    • 14. Darton TC, Guiver M, Naylor S, Kaczmarski EB, Borrow R, Read RC. Bacterial genomic detection within cerebrospinal fluid of patients with meningococcal disease is influenced by microbial and host characteristics. Clin Infect Dis Official Publ Infect Dis Soc Am 2011;53(5):463e7 [Epub 2011/07/30].
    • 15. Lepur D, Barsic B. Community-acquired bacterial meningitis in adults: antibiotic timing in disease course and outcome. Infection 2007;35(4):225e31 [Epub 2007/07/25].
    • 16. Thompson MJ, Ninis N, Perera R, Mayon-White R, Phillips C, Bailey L, et al. Clinical recognition of meningococcal disease in children and adolescents. Lancet 2006;367(9508):397e403 [Epub 2006/02/07].
    • 17. de Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002;347(20):1549e56 [Epub 2002/11/15].
    • 18. Everett DB, Cornick J, Denis B, Chewapreecha C, Croucher N, Harris S, et al. Genetic characterisation of Malawian pneumococci prior to the roll-out of the PCV13 vaccine using a highthroughput whole genome sequencing approach. PloS One 2012;7(9):e44250 [Epub 2012/09/13].
    • 19. Desmond NA, Nyirenda D, Dube Q, Mallewa M, Molyneux E, Lalloo DG, et al. Recognising and treatment seeking for acute bacterial meningitis in adults and children in resource-poor settings: a qualitative study. PloS One 2013;8(7):e68163 [Epub 2013/07/19].
    • 20. Mai NT, Tuan TV, Wolbers M, Hoang DM, Nga TV, Chau TT, et al. Immunological and biochemical correlates of adjunctive dexamethasone in Vietnamese adults with bacterial meningitis. Clin Infect Dis Official Publ Infect Dis Soc Am 2009;49(9): 1387e92 [Epub 2009/10/10].
    • 21. Handa S. Concentrations of interleukin-1 beta, interleukin-6, interleukin-8 and TNF-alpha in cerebrospinal fluid from children with septic or aseptic meningitis. Kurume Med J 1992; 39(4):257e65 [Epub 1992/01/01].
    • 22. Goonetilleke UR, Scarborough M, Ward SA, Gordon SB. Proteomic analysis of cerebrospinal fluid in pneumococcal meningitis reveals potential biomarkers associated with survival. J Infect Dis 2010;202(4):542e50 [Epub 2010/07/09].
    • 23. Wippel C, Maurer J, Fortsch C, Hupp S, Bohl A, Ma J, et al. Bacterial cytolysin during meningitis disrupts the regulation of glutamate in the brain, leading to synaptic damage. PloS Pathog 2013;9(6):e1003380 [Epub 2013/06/21].
    • 24. Kelly MJ, Benjamin LA, Cartwright K, Ajdukiewicz KM, Cohen DB, Menyere M, et al. Epstein-barr virus coinfection in cerebrospinal fluid is associated with increased mortality in Malawian adults with bacterial meningitis. J Infect Dis 2012; 205(1):106e10 [Epub 2011/11/15].
    • 25. Bangert M, Bricio-Moreno L, Gore S, Rajam G, Ades EW, Gordon SB, et al. P4-mediated antibody therapy in an acute model of invasive pneumococcal disease. J Infect Dis 2012; 205(9):1399e407 [Epub 2012/03/30].
    • 26. Bangert M, Wright AK, Rylance J, Kelly MJ, Wright AD, Carlone GM, et al. Immunoactivating peptide P4 augments alveolar macrophage phagocytosis in two diverse human populations. Antimicrob Agents Chemother 2013 Sep;57(9):4566e9. http://dx.doi.org/10.1128/AAC.00742-13.
    • 27. French N, Gordon SB, Mwalukomo T, White SA, Mwafulirwa G, Longwe H, et al. A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults. N Engl J Med 2010;362(9): 812e22 [Epub 2010/03/05].
  • No similar publications.

Share - Bookmark

Funded by projects

  • WT | Pulmonary defence and suscep...
  • WT | Wellcome Trust Clinical PhD ...

Cite this article